Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -182,814 | -108,897 | -101,252 | -65,782 | -55,144 |
| Depreciation Amortization | 869 | 841 | 1,765 | 1,737 | 1,564 |
| Accounts receivable | 13,903 | -17,853 | 1,824 | 2,651 | -2,525 |
| Other Working Capital | 26,875 | -872 | -3,530 | 9,327 | -7,551 |
| Other Operating Activity | 6,059 | 37,197 | 8,628 | 10,924 | 10,218 |
| Operating Cash Flow | $-135,108 | $-89,584 | $-92,565 | $-41,143 | $-53,438 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -6,342 | 78,277 | 5,134 | -64,326 | 28,546 |
| PPE Investments | -514 | -343 | -366 | -316 | -5,273 |
| Investing Cash Flow | $-6,856 | $77,934 | $4,768 | $-64,642 | $23,273 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 119,867 | 19,477 | 10,353 | N/A | 22,658 |
| Debt Repayment | -52,420 | N/A | -4,025 | N/A | N/A |
| Common Stock Issued | 95,725 | 59,739 | 56,252 | 135,581 | 317 |
| Other Financing Activity | 137,417 | 19,882 | -76 | 122 | 329 |
| Financing Cash Flow | $300,589 | $99,098 | $62,504 | $135,703 | $23,304 |
| Beginning Cash Position | 115,723 | 28,275 | 53,568 | 23,650 | 30,511 |
| End Cash Position | 274,348 | 115,723 | 28,275 | 53,568 | 23,650 |
| Net Cash Flow | $158,625 | $87,448 | $-25,293 | $29,918 | $-6,861 |
| Free Cash Flow | |||||
| Operating Cash Flow | -135,108 | -89,584 | -92,565 | -41,143 | -53,438 |
| Capital Expenditure | -514 | -343 | -366 | -328 | -5,277 |
| Free Cash Flow | -135,622 | -89,927 | -92,931 | -41,471 | -58,715 |